, Hong Kong
271 views

Zylox-Tonbridge estimates $2.37b gains in global offering

The company has set its offer price at $42.7 per share.

Zylox-Tonbridge Medical Technology Co. Ltd. is expecting to gain some $2.37 billion in net proceeds from the global offering after it set its offer price at $42.7 per share.

The company will be offering 60 million H Shares, of which 30 million will be for Hong Kong, whilst the remaining will be under international offering.

Zylox-Tonbridge plans to earmark 40% of the net proceeds, or $959.5 million, to its 38 other products and pipeline candidates in order to develop their product portfolio to provide a total solution.

Some 37% or $888.1 million will be allocated to its core products, namely Thrombite CRD and Ultrafee DCB; whilst 11% or $262.2 million will fund ongoing research and development (R&D), production, and commercialization of its five major products.

This includes the neurovascular embolization coil, flow diverter, retrievable inferior vena cava filter, peripheral venous stent system, and suture-mediated closure system. Four of which are already in the clinical stage and one is in registrational stage.

The remaining portion will be for the upgrade of its R&D facility ($71.9 million), potential strategic acquisitions, investments, in-licensing or collaborations ($95.9 million), and for working capital and general corporate purposes ($119.9 million).

Follow the link for more news on

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!